Neuren Pharmaceuticals | NEU - Net Income

Stock Price
11.33
Daily Change
-0.15 -1.31%
Monthly
-13.31%
Yearly
-10.08%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD15.4M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Clinuvel Pharmaceuticals AUD 24.7M 13.76M Jun/2024
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Genetic Signatures AUD -15.2M 7.81M Dec/2024
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
Medical Developments International AUD -226K 121K Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Organon & Co USD 160M 15M Sep/2025
Paradigm Biopharmaceuticals AUD -6.42M 495.95K Jun/2025
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Starpharma Holdings AUD 1.37M 3.67M Dec/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025